About Immune Tolerance Network

The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Our mission is to accelerate the clinical development of immune tolerance therapies in asthma and allergy, autoimmune diseases, type 1 diabetes and solid organ transplantation.

Immune tolerance therapies reprogram the immune system so that disease-causing immune responses are stopped while maintaining the immune system’s ability to combat pathogen infection. The ITN develops, funds and conducts clinical trials in conjunction with mechanistic, laboratory based studies.

website icon
Website
employees icon
Employees
industry icon
Industry
Research
location icon
Location
US

Frequently Asked Questions about Immune Tolerance Network

Who are the decision makers in Immune Tolerance Network?

The decision makers in Immune Tolerance Network are Jared Hennessy, Laura Cooney, Lauren Higdon, etc. Click to Find Immune Tolerance Network decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more